AlayaCare, Dialogue among projects receiving $3.4 million from Scale AI supercluster

“With projects that include analysis tools for research and clinical trials, coordination of patient services, supply management for drugs, medical equipment, and food and essentials, AI has once again demonstrated its ability to support all sectors in improving their efficiency,” Billot added. “The collective fight against COVID-19 highlights the exceptional work of the care teams deployed for patients,” said Naomi Goldapple, head of AlayaLabs at AlayaCare. The system aims to facilitate quick access to information for citizens and allow healthcare professionals to focus on tasks that require their expertise. This is also a spirit of science, where the emphasis is on the joy of understanding, sharing and discovering solutions together.” Creative Destruction Lab (CDL) which received $500,000 from both Scale AI and overall, is adapting its mentorship program to help startups to face the challenges by COVID-19 in terms of public health and economic recovery. Finally, the Montreal Heart Institute will develop an intelligent infrastructure to oversee clinical trials by optimizing the management of informed patient consent, as well as the capture, filtering and analysis of data from a treatment evaluation study based on colchicine to reduce mortality from COVID-19.